
The average Pharmavite VP of Investor Relations earns an estimated $123,525 annually. Pharmavite's VP of Investor Relations compensation is $7,883 less than the US average for a VP of Investor Relations.
Last updated 5 months ago.
The majority of VPs of Investor Relations at Pharmavite believe they're compensated fairly. 50% of VPs of Investor Relations at Pharmavite say they receive annual bonuses, and the vast majority (100%) are satisfied with their benefits. See more compensation ratings at Pharmavite